Pulmonary hypertension (PH) is characterized by enhanced vasoreactivity and sustained pulmonary vasoconstriction, arising from aberrant Ca 2+ homeostasis in pulmonary arterial (PA) smooth muscle cells. In addition to Ca 2+ , magnesium, the most abundant intracellular divalent cation, also plays crucial roles in many cellular processes that regulate cardiovascular function.
INTRODUCTION
Pulmonary hypertension (PH) is a group of clinical syndromes with the presentation of elevated pulmonary artery (PA) pressure. It is characterized by pulmonary vascular disorders and increased pulmonary vascular resistance (Humbert, Sitbon, & Simonneau, 2004) . (Stenmark & McMurtry, 2005) . It has been suggested that disordered Ca 2+ homeostasis in vascular smooth muscle cells was closely related to vascular disorders of PH (Lin et al., 2004) , and the role of Ca 2+ in PH has been widely studied.
Magnesium, the most abundant intracellular divalent cation, also plays crucial roles in many physiological, biochemical and cellular processes regulating cardiovascular functions (Kolte, Vijayaraghavan, Khera, Sica, & Frishman, 2014) . It is involved in the modulation of vascular smooth muscle tone and endothelial cell function (Champagne, 2008; Laurant & Touyz, 2000) . Acting as a Ca 2+ channel antagonist, magnesium inhibits Ca 2+ entry and Ca 2+ release in the vascular smooth muscle cells through a variety of mechanisms (Bara & Guiet-Bara, 2001; Mubagwa, Gwanyanya, Zakharov, & Macianskiene, 2007; Yoshimura et al., 1997) . Magnesium also regulates vascular tone by altering the vascular responses to vasodilator and vasoactive agonists (Soltani, Keshavarz, Sohanaki, Dehpour, & Zahedi Asl, 2005a) . Besides the direct effects of magnesium on vascular smooth muscle cells, magnesium affects endothelial function by modulating vasodilatation (Landau, Scott, & Smiley, 2004; Satake et al., 2004; Soltani, Keshavarz, Sohanaki, Zahedi Asl, & Dehpour, 2005b) . Thus, magnesium, with regulatory roles on vascular tone and reactivity, could affect blood pressure and is central to the aetiopathology of hypertension. Hypertension is a complex and multifactorial disease, with increased vascular contraction and decreased vascular dilatation (Virdis & Taddei, 2011) . Epidemiological, experimental and clinical studies have confirmed the role of magnesium deficiency in the pathogenesis of hypertension (Kesteloot & Joossens, 1988 ). An inverse correlation between magnesium concentrations and blood pressure has been demonstrated (Cunha, Umbelino, Correia, & Neves, 2012) . The hypotensive action of magnesium supplementation has been reported in multiple animal models of hypertension (Kh, Khullar, Kashyap, Pandhi, & Uppal, 2000; Mervaala et al., 1997; Touyz & Milne, 1999) . The effect of magnesium on regulating vascular tone and reactivity might be one of the mechanisms underlying these processes.
Nitric oxide (NO), a crucial signalling molecule, is involved in numerous physiological and pathophysiological cardiovascular functions (Nagano, 1999) . The generation of NO in mammals mainly relies on the activity of nitric oxide synthase (NOS). Studies on NOS inhibition-induced hypertensive rats suggested that high magnesium improves vascular reactivity of mesenteric arteries (Basralı et al., 2015) , and infusion of magnesium sulphate could improve persistent PH of the newborn (Chandran, Haqueb, Wickramasinghe, & Wint, 2004; Daffa & Milaat, 2002) . In addition, studies on experimental PH showed that magnesium sulphate decreased mean pulmonary arterial pressure and improved cardiac output (Beghetti, Spahr-Schopfer, Mensi, Morel, & Rimensberger, 2003; Haas, Kemke, Schulze-Neick, & Lange, 2004; Yoshioka et al., 2001) . However, the role of magnesium in regulating pulmonary vascular tone has rarely been studied.
Thus, in the present study we hypothesized that magnesium might play an important role in the regulation of pulmonary vascular function.
To explore this hypothesis, we used a mouse model of chronic hypoxic pulmonary hypertension (CHPH) to examine the effects of magnesium on the endothelin-1 (ET-1)-induced contractile response, and the ACh-induced endothelium-dependent vasodilatation and NO production in PAs of control and CHPH mice. Our results clearly demonstrate differential roles of magnesium in pulmonary vasoreactivity, and these processes are altered in CHPH.
New Findings
• What is the central question of this study?
The central goal of this study was to elucidate the role of magnesium in the regulation of pulmonary vascular reactivity in relationship to hypoxic pulmonary hypertension.
• What is the main finding and its importance?
We found that magnesium is essential for normal vasoreactivity of the pulmonary artery. Increasing the magnesium concentration attenuates vasoconstriction and improves vasodilatation via release of nitric oxide.
Pulmonary hypertension is associated with endothelial dysfunction resulting in the suppression of magnesium modulation of vasodilatation. These results provide evidence that magnesium is important for the modulation of pulmonary vascular function.
METHODS

Ethical approval
Animal care and procedures and were approved by the Fujian Medical 
Exposure to chronic hypoxia
The method for developing CHPH has been described extensively in previous studies (Lin et al., 2004; Nomura et al., 2003; Pei et al., 2006) .
The experimental animals were purchased from the Laboratory Animal Center of Fujian Medical University [License Key: SCXK (min) 2012-0001]. Male ICR mice (18-25 g) were placed either in room air or in a hypoxic chamber at 10 ± 0.5% O 2 for 3 weeks. Cages were cleaned regularly, with food and water provided ad libitum.
Measurement of haemodynamic parameters and right heart hypertrophy
Twenty-one days after commencing exposure to hypoxia, mice were weighed and anaesthetized with sodium pentobarbital (50 mg kg −1 , I.P. Biotech Pharma, Beijing Shi, China). Pulmonary hypertension was evaluated by measuring pulmonary arterial systolic pressure (PASP) and right ventricular hypertrophy. After the righting reflex and irritation-pain response disappeared, mice were ventilated with a volume-controlled ventilator [0.018 ml (g body weight) −1 ; Inspira ASV;
Harvard Apparatus, Holliston, MA, USA]. The PASP was monitored using a Mikro-Tip pressure catheter (SPR-1000; Millar Instruments, established by three 10 min exposures to 60 mM KCl. The rings were then exposed to phenylephrine (Phen; 1 M) followed by ACh (10 M) to verify the integrity of the endothelium. The active tension induced by the agonist was normalized to the maximal tension generated by 60 mM KCl.
Measurement of isometric tension of intralobar PAs
Experimental protocols for arteries
Pulmonary rings with and without endothelium were incubated for 1 h in Krebs solution that was magnesium free (0.0 mM) or had normal (1.2 mM) or high (4.8 mM) magnesium concentrations, before and during the applied protocols. During this period, the bath solution was changed every 15 min. In between all of the protocols applied, the vascular segments were left to rest for 30 min.
Assessment of vasoconstrictor responses to ET-1
The contractions of the PA rings with and without endothelium from normal or CHPH mice were examined by adding cumulative doses of ET-1 (from 10 −11 to 3 × 10 −8 M) to the bath solution.
Assessment of vasodilatation responses to ACh
Before dose-response curves were initiated, all arterial rings with endothelium were preconstricted with Phen (10 −6 M). Endotheliumdependent relaxation was assessed using ACh (10 −8 -10 −5 M). The
ACh-induced concentration-dependent relaxations were re-examined after pretreatment with L-NAME (100 M) for 30 min. The steady state of contraction induced by Phen was considered to be 100%, and the relaxation responses were calculated as percentages of this contraction.
Simultaneous measurements of NO production and myography
The generation of NO and pulmonary vascular tension in response to Phen and ACh were detected by using a wire-myograph system and confocal laser scanning microscopy imaging technique. The measurement of isometric tension of intralobar PAs was performed as mentioned (Mu, Yan, Lin, Zheng, & Lin, 2017) . Then PA rings were Ti-E laser scanning confocal microscope (C2; Nikon, Japan) with a ×20
objective lens. The DAF-FM DA fluorescence was calibrated using the
where F bg is background fluorescence and F b is the fluorescence baseline determined in situ in rings with DAF-FM DA.
Data analysis
All data are represented as means ± SD; n indicates the number of animals or experiments as specified in the text. Statistical significance (P < 0.05) of the changes was determined with Student's paired or unpaired t test or ANOVA wherever applicable.
RESULTS
Chronic hypoxia-induced pulmonary hypertension in mice
To verify successful generation of the PH model, haemodynamic parameters of normoxic mice and those exposed to chronic hypoxia (CH) were measured, and right heart hypertrophy was determined.
After 3 weeks of exposure to hypoxia, PASP was increased from
19.73 ± 1.93 (n = 10, normoxic) to 38.48 ± 4.51 mmHg (n = 10, CH; P < 0.01) in CH mice. Likewise, CH caused an elevation of RVMI (CH, 36.00 ± 5.43%, n = 7; normoxic, 23.10 ± 2.22%, n = 11; P < 0.01; Figure 2a -d) . These data suggested the successful generation of the PH model. Furthermore, ET-1-induced contraction in endothelium-intact (EC + ) and endothelium-disrupted (EC − ) PAs from PH mice was increased compared with PAs from normoxic mice in normal magnesium solution (Figure 2e ,f), consistent with our previous studies in CHPH rats (Jiao et al., 2016; Wang et al., 2015) .
Effects of magnesium on ET-1-induced contraction of PAs with disrupted and intact endothelium from normoxic mice
After the equilibration period, the PA rings were contracted by cumulative addition of ET-1 (from 10 −11 to 3 × 10 −8 M). Endothelin-1 caused a concentration-dependent contractile response in EC − and EC + PA rings from normoxic mice bathed in Krebs solution containing no magnesium, normal magnesium (1.2 mM) or high magnesium (4.8 mM). In EC − PA rings, the maximal response (E max value) to ET-1 was depressed in magnesium-free (85.40 ± 12.15%, n = 8; P < 0.01) and high-magnesium solution (93.18 ± 18.13%, n = 16; P < 0.01) compared with normal-magnesium solution (122.12 ± 14.88%, n = 16;
Figure 3a-e), whereas the EC 50 of vasoconstriction was increased only in high-magnesium solution (0.0 mM, 2.36 ± 1.19 nM, n = 8; 1.2 mM,
1.57 ± 0.75 nM, n = 16; 4.8 mM, 2.97 ± 1.08 nM, n = 16; P < 0.01; Figure 3j ). These results indicate that magnesium is essential for normal reactivity of PAs, and high magnesium significantly depressed the ET-1-induced contractile responses in normoxic mice.
Compared with EC − PA rings, presence of the endothelium lowered the ET-1-induced maximal contraction (109.35 ± 9.40%, n = 12; P < 0.05; Figure 3e ) and increased the EC 50 of vasoconstriction (2.53 ± 0.46, n = 12; P < 0.01; Figure 3j ) in the presence of normal magnesium. The attenuation of the maximal ET-1 response and the increase of EC 50 were more pronounced in high-magnesium solution (E max , 73.89 ± 20.38%, n = 8, P < 0.05; EC 50 , 5.29 ± 2.18 nM, n = 8, P < 0.01), but these differences were not observed in magnesium-free solution (E max , 86.34 ± 6.21%, n = 8; EC 50 , 2.74 ± 0.66 nM, n = 8;
Figures 3e,j). It was thus obvious that high magnesium could inhibit the contraction of PAs by a direct action, as well as by promoting endothelium-dependent vasodilatation. 
Effects of magnesium on ACh-induced relaxation of PAs with intact endothelium from normoxic mice
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Effects of magnesium on intracellular NO production in PAs
To evaluate the direct effect of magnesium in ACh-induced endothelial NO production, endothelium-intact PAs were mounted on a myograph, loaded with the NO-fluorescent indicator DAF-FM DA (Kojima et al., 1999) These results provide the direct evidence that extracellular magnesium potentiates ACh-dependent NO production in pulmonary endothelial cells.
Effects of magnesium on ET-1-induced contraction of PAs with disrupted and intact endothelium from CH mice
Endothelin-1 produced a concentration-dependent contractile response in EC − (Figure 6a-c) and EC + PA rings (Figure 6f-h ) from CH mice in magnesium-free, normal-magnesium or high-magnesium solution. The contractile responses to ET-1 were significant greater in normal-magnesium than in magnesium-free or high-magnesium solution (Figure 6d,i) . In the EC − group, the E max to ET-1 was reduced in magnesium-free (78.68 ± 10.68%, n = 10, P < 0.01) and Compared with EC − PA rings, the presence of endothelium suppressed ET-1-induced contraction (EC − , 138.63 ± 9.83%, n = 9; EC + , 125.36 ± 10.00%, n = 7; P < 0.05; Figure 6e ) in normal-magnesium solution, but there was no difference in the response in magnesiumfree or high-magnesium conditions. Moreover, there was no difference in the EC 50 of vasoconstriction between the EC − and EC + group in CH mice. These results suggest that magnesium might directly inhibit the contractile response of PA smooth muscle, whereas its effect on endothelium-dependent vasodilatation might be abolished in PAs of CH mice.
Effects of magnesium on ACh-induced concentration-dependent relaxation of PAs with intact endothelium from CH mice
The EC + PAs from CH mice exhibited endothelium-dependent vasodilatation. However, the ACh-induced vasodilatation was not significantly different between magnesium-free (E max , 20.69 ± 19.58%, n = 11), normal-magnesium (35.35 ± 22.84%, n = 8) and highmagnesium conditions (30.84 ± 8.14%, n = 8; Figure 7a ). Compared with EC + PAs of normoxic mice, the endothelium-dependent vasodilatation in PAs of CH mice was significantly decreased in magnesium-free (Figure 7b ), normal-magnesium (Figure 7c ) and highmagnesium solutions (Figure 7d ). These results suggest that CH caused 
DISCUSSION
The present study examined the effects of magnesium on the contractile response and endothelium-dependent vasodilatation in PAs of Pulmonary hypertension is characterized by increased pulmonary arterial pressure and eventually leads to right heart hypertrophy and failure (Humbert et al., 2004) . Chronic exposure to hypoxia causes an abnormal increase in pulmonary vascular resistance and is generally used to induce PH. In the present study, mice exposed to 3 weeks In addition, endothelial dysfunction is suggested to be involved in the pathogenesis of CHPH. Chronic hypoxic exposure could cause an imbalance of oxidant and antioxidant systems, resulting in vascular endothelial injury (Stenmark, Fagan, & Frid, 2006) . Our finding of significant suppression of ACh-induced vasodilatation in EC + PAs of CHPH mice is consistent with the notion that CH exposure causes endothelial dysfunction in PAs.
Magnesium is an important modulator of vascular tone that can attenuate agonist-induced vasoconstriction and improve vasorelaxation. In the present study, magnesium exhibited dual effects on the ET-1-induced PA contraction, such that either a high concentration of magnesium or magnesium removal attenuated the ET-1-induced response. The dual effects of magnesium are likely to be related to its diverse physiological and cellular functions. Magnesium, as the second-most abundant intracellular cation, participates in numerous enzymatic functions related to the pharmaco-contraction coupling in vascular smooth muscle, including ATP production, interactions of actin with myosin, G-protein activity, phospholipase C translocation and protein kinase C activation (Kolte et al., 2014 (Bootman, Missiaen, Parys, De Smedt, & Casteels, 1995; Watras & Benevolensky, 1987) . All these mechanisms could lead to the attenuation of ET-1-induced PA contraction at a high magnesium concentration. The dual effects of magnesium on ET-1-induced PA contraction are consistent with previous reports in systemic arteries (Ko, Park, & Earm, 2004; Laurant & Berthelot, 1996; Laurant, Touyz, & Schiffrin, 1997) .
Besides the effects on vascular contraction, magnesium can also improve vasodilatation by modulating endothelial function. The vascular endothelium plays a fundamental role in regulation of vasomotor tone by synthesizing and releasing prostacyclin and NO. High magnesium was reported to improve endothelial function, whereas low magnesium led to endothelial dysfunction (Maier, Bernardini, Rayssiguier, & Mazur, 2004a; Maier, Malpuech-Brugere, Zimowska, Rayssiguier, & Mazur, 2004b) . In normoxic mice, the presence of endothelium attenuated the contraction of PAs induced by ET-1 in normaland high-magnesium conditions. These results are in agreement with previous studies suggesting that magnesium contributes to the endothelium-dependent relaxation (Landau et al., 2004; Satake et al., 2004; Soltani et al., 2005b) . Moreover, magnesium removal completely abolished the attenuation of the ET-1-induced vasoconstriction in the EC + PAs, suggesting that magnesium is required for endotheliumdependent relaxation. In contrast, removal of the endothelium has little or no influence on the ET-1-induced contraction in PAs of CHPH mice in normal-and high-magnesium conditions. The disappearance of the effect of magnesium on vasorelaxation might be attributable to endothelial dysfunction in CHPH mice. In addition, previous studies have shown that the relaxant action of magnesium was mediated by the endothelial release of NO (Pearson, Evora, Seccombe, & Schaff, 1998; Satake et al., 2004) .
Nitric oxide is an important vasodilatory factor synthesized and released by vascular endothelial cells. It plays a crucial role in the regulation of vascular tone through its direct effect on vascular smooth muscle to stimulate guanylate cyclase for production of cyclic guanosine monophosphate. A previous study has shown that magnesium promotes the release of NO in a concentration-dependent manner in endothelium-intact rat aortic rings (Yang, Gebrewold, Nowakowski, Altura, & Altura, 2000) . In the present study, ACh induced concentration-dependent relaxation in PAs of normoxic mice. The ACh-induced relaxation was greatly suppressed when magnesium was absent and was slightly enhanced by high magnesium even though the difference was not statistically significant. This is probably because the effect of ACh in normal-magnesium conditions is already optimal. The relaxant effect of ACh and its modulation by magnesium were suppressed by L-NAME in magnesium-free, normal-and high-magnesium conditions. L-NAME is considered to be a general NOS antagonist that targets all three known NOS isoforms (endothelial, inducible and neuronal NOS) to prevent NO production and bioavailability (Bradman et al., 2011) . To verify whether the improvement of the ACh-induced relaxation in normoxic PA by magnesium is attributable to enhanced release of NO, we performed the NO measurement in intact PAs using the NO-sensitive dye DAF- CH and monocrotaline-induced PH rats (Lu & Wang, 1991; Mathew, Gloster, Altura, & Altura, 1988) . Magnesium sulphate infusion has been used for the treatment of persistent pulmonary hypertension of the newborn in some developing countries (Chandran et al., 2004; Daffa & Milaat, 2002) . It will be interesting to examine further the chronic effects of magnesium on the alterations in vascular functions related to PH. the paper. The authors thank the laboratory team for their technical assistance.
